Search - Archive ouverte HAL Access content directly

Filter your results

10 Results
authFullName_s : Fabrice Balavoine

Two-Dimensional Crystallization of a Histidine-Tagged Protein on Monolayers of Fluidity-Enhanced Ni 2+ -Chelating Lipids

Sébastien Courty , Luc Lebeau , Laurence Martel , Pierre-François Lenne , Fabrice Balavoine et al.
Langmuir, 2002, 18 (24), pp.9502-9512. ⟨10.1021/la026261z⟩
Journal articles istex hal-02361445v1
Image document

QGC606: A Best-in-Class Orally Active Centrally Acting Aminopeptidase A Inhibitor Prodrug for Treating Heart Failure Following Myocardial Infarction

Solène E Boitard , Mathilde Keck , Robin Deloux , Pierre-Emmanuel Girault-Sotias , Yannick Marc et al.
Canadian Journal of Cardiology, 2022, 38 (6), pp.815-827. ⟨10.1016/j.cjca.2022.01.019⟩
Journal articles hal-03834295v1

A pilot double-blind randomized placebo-controlled crossover pharmacodynamic study of the centrally active aminopeptidase A inhibitor, firibastat, in hypertension

Michel Azizi , Pierre-Yves Courand , Thierry Denolle , Pascal Delsart , Valentina Zhygalina et al.
Journal of Hypertension, 2019, 37 (8), pp.1722-1728. ⟨10.1097/HJH.0000000000002092⟩
Journal articles hal-03149099v1

Immobilization of Histidine-Tagged Proteins on Functionalized Carbon Nanotubes

Cyrille Richard , Fabrice Balavoine , Patrick Schultz , Nicole Moreau , Charles Mioskowski et al.
Journal of Bionanoscience, 2007, 1 (2), pp.106-113. ⟨10.1166/jbns.2007.019⟩
Journal articles hal-03827742v1
Image document

Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice

Solène Emmanuelle Boitard , Yannick Marc , Mathilde Keck , Nathalie Mougenot , Onnik Agbulut et al.
Journal of Molecular and Cellular Cardiology, 2019, 127, pp.215-222. ⟨10.1016/j.yjmcc.2018.12.008⟩
Journal articles hal-02265448v1

A new strategy for treating hypertension by blocking the activity of the brain renin–angiotensin system with aminopeptidase A inhibitors

Ji Gao , Yannick Marc , Xavier Iturrioz , Vincent Leroux , Fabrice Balavoine et al.
Clinical Science, 2014, 127 (3), pp.135-148. ⟨10.1042/CS20130396⟩
Journal articles hal-02153715v1

Randomised, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Study of QGC001, a Centrally Acting Aminopeptidase A Inhibitor Prodrug

Fabrice Balavoine , Michel Azizi , Damien Bergerot , Nadia de Mota , Remi Patouret et al.
Clinical Pharmacokinetics, 2014, 53 (4), pp.385-395. ⟨10.1007/s40262-013-0125-y⟩
Journal articles hal-03292696v1

Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension.

Laurence Bodineau , Alain Frugière , Yannick Marc , Nicolas Inguimbert , Céline Fassot et al.
Hypertension, 2008, 51 (5), pp.1318-25. ⟨10.1161/HYPERTENSIONAHA.107.098772⟩
Journal articles inserm-00422685v1

Supramolecular Self-Assembly of Lipid Derivatives on Carbon Nanotubes

Cyrille Richard , Fabrice Balavoine , Patrick Schultz , Thomas Ebbesen , Charles Mioskowski et al.
Science, 2003, 300 (5620), pp.775-778. ⟨10.1126/science.1080848⟩
Journal articles hal-03827756v1

NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating Hypertension

Mathilde Keck , Hugo de Almeida , Delphine Compère , Nicolas Inguimbert , Adrien Flahault et al.
Hypertension, 2019, 73 (6), pp.1300-1307. ⟨10.1161/HYPERTENSIONAHA.118.12499⟩
Journal articles hal-02265480v1